Over the past two decades, there has been continuous advancement in the accuracy and
complexity of continuous glucose monitoring devices. Continuous glucose monitoring …

Ultra-rapid-acting insulin analogs (URAA) are a further development and refinement of rapid-
acting insulin analogs. Because of their adapted formulation, URAA provide an even faster …

Aims The dawn phenomenon (DP) is an abnormal early morning blood glucose rise without
nocturnal hypoglycaemia, which can be more easily and precisely assessed with continuous …

Abstract Purpose Haptoglobin (Hp) is a hemoglobin-binding protein that functions as an
antioxidant in human plasma. It is reported that glycemic variability (GV) plays a key role in …

Aim To evaluate the efficacy and safety of URLi (ultra rapid lispro insulin) compared to
insulin lispro as bolus insulin with basal insulin using CGM in the individuals with type 2 …

Purpose Sudomotor dysfunction is considered as one of the earliest manifestations of
diabetic peripheral neuropathy. We aimed to investigate the association between sudomotor …

Background: Mechanistically, subcutaneous ultra-rapid lispro (URLi) is faster than lispro.
Whether this translates into a better post-prandial glucose (PPG) and glycemic control in …

Abstract Type 2 diabetes (T2D) is characterised by defects in both fasting and postprandial
glucose (PPG) control. Many Asians including Chinese people with T2D have isolated high …